Loading
A phase 3 trial of Methoxsalen in Cutaneous T-cell lymphoma and Peripheral T-cell lymphomas, run by Medical University of Graz, completed.
PUVA Maintenance Therapy in Mycosis Fungoides is a phase 3 interventional study registered as NCT01686594 by Medical University of Graz, with 28 participants recorded, started 2013-02 and reaching its primary completion in 2018-07-02. Interventions recorded: 8-methoxypsoralen. Conditions recorded: Patch/Plaque Stage Mycosis Fungoides.
Linked to the drug Methoxsalen because the registry names it among its interventions and Cutaneous T-cell lymphoma and Peripheral T-cell lymphomas among its conditions. Registry record only: no result has been read by an editor.
Shares Methoxsalen (extracorporeal photopheresis), Cutaneous T-cell lymphoma (mycosis fungoides and Sezary syndrome), Peripheral T-cell lymphomas (including cutaneous T-cell lymphoma) and the tag pipeline.
Shares Methoxsalen (extracorporeal photopheresis) and the tag pipeline.
Shares Cutaneous T-cell lymphoma (mycosis fungoides and Sezary syndrome), Peripheral T-cell lymphomas (including cutaneous T-cell lymphoma) and the tag pipeline.
Shares Cutaneous T-cell lymphoma (mycosis fungoides and Sezary syndrome), Peripheral T-cell lymphomas (including cutaneous T-cell lymphoma) and the tag pipeline.
Shares Cutaneous T-cell lymphoma (mycosis fungoides and Sezary syndrome), Peripheral T-cell lymphomas (including cutaneous T-cell lymphoma) and the tag pipeline.
Shares Cutaneous T-cell lymphoma (mycosis fungoides and Sezary syndrome), Peripheral T-cell lymphomas (including cutaneous T-cell lymphoma) and the tag pipeline.
Shares Peripheral T-cell lymphomas (including cutaneous T-cell lymphoma) and the tag pipeline.
Shares Peripheral T-cell lymphomas (including cutaneous T-cell lymphoma) and the tag pipeline.